Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Establishment of Health Clinics As Mass Screening and Referral Systems for Chronic Non-Communicable Diseases in Primary Health Care



Heidari K1 ; Sajjadi SA1 ; Hadian R1 ; Hadi S1 ; Hosseinkhani R1 ; Amini S1 ; Kiani Z1 ; Ajami A1 ; Fadaei R1 ; Shahriari A1 ; Keramatian K1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Health, Isfahan Provincial Health Office, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Preventive Medicine Published:2012

Abstract

Background: This study aimed to establish a comprehensive screening and referral system for chronic non-communicable diseases (CNCD) in the routine primary health care, and to determine the prevalence of diabetes, pre-diabetes, metabolic syndrome, and dyslipidemia in adult population invited by public announcement to the Health clinics in Isfahan, Iran. Methods: This survey was conducted from March 2010, and the current paper presents data obtained until November 2011. To provide health services for prevention and control of CNCDs, with priority of type2 diabetes mellitus, Health clinics were established in different parts of Isfahan city with a population of approximately 2,100,000 in Iran. The general populations aged 30 years and above were invited to the Health clinics by public announcement. Results: A total of 198972 participants were screened. The mean age of participants was 47.8 years (48.5 men, 47.3 women), with a range of 1 to 95 years old and standard deviation of 12.3 years (12.7 men, 12.1 women). Overall, 22% of participants had impaired fasting glucose, 25% had hypercholesterolemia, 31% had hypertriglyceridemia, and 20% had metabolic syndrome. Conclusion: The high prevalence of dysglycemia and diabetes in our survey may serve as confirmatory evidence about the importance of mass screening and early diagnosis of CNCDs' risk factors. Our model of establishing Health clinics, as a comprehensive referral system in the routine primary health care can be adopted by Middle Eastern countries, where CNCDs notably diabetes are an emerging health problem.
Related Docs
View other Related Docs
1. Metabolic Syndrome in First Degree Relatives of Patients With Type 2 Diabetes: Incidence and Risk Factors, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2011)
2. The Prevalence and Correlated Determinants of Hypertension and Type 2 Diabetes:A Large Community-Based Study in Isfahan, Iran, Pakistan Journal of Medical Sciences (2012)
3. Prevalence and Risk Factors of Diabetes, Pre-Diabetes and Metabolic Syndrome in First-Degree Relatives of Patients With Type Ii Diabetes, Journal of Kerman University of Medical Sciences (2013)
4. First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East: The National Survey of Risk Factors for Noncommunicable Diseases of Iran, Diabetes Care (2009)
5. Weight Status of the First-Degree Relatives of Patients With Type 2 Diabetes Based on the Glucose Tolerance Test, Journal of Research in Medical Sciences (2012)
6. Metabolic Syndrome: An Emerging Public Health Problem in Iranian Women: Isfahan Healthy Heart Program, International Journal of Cardiology (2008)
7. Assessment of Caring Status for Patients With Type 2 Diabetes in Under Control Health Centers of Jarghoyee Region in Isfahan, Iran, Journal of Isfahan Medical School (2017)
8. The Effect of Quality of Care on Cardiovascular Risk Factors in Newly Diagnosed Diabetic Patients, International Journal of Preventive Medicine (2014)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (84)
Roya Kelishadi (83)
Other Related Docs
9. The Modifiable Noncommunicable Risk Factors Among an Iranian Population, Southeast Asian Journal of Tropical Medicine and Public Health (2012)
10. Evaluation of the Finnish Diabetes Risk Score (Findrisc) As a Screening Tool for the Metabolic Syndrome, The review of diabetic studies : RDS (2013)
11. Quality of Care for First-Degree Relatives of Type 2 Diabetes Patients Diagnosed With Diabetes at a Screening Program One Year After Diagnosis, Review of Diabetic Studies (2008)
12. Finnish Diabetes Risk Score to Predict Type 2 Diabetes in the Isfahan Diabetes Prevention Study, Diabetes Research and Clinical Practice (2013)
13. Low-Density Lipoprotein Cholesterol and Metabolic Syndrome in an Iranian High-Risk Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2015)
14. Does the Impact of Metabolic Syndrome on Cardiovascular Events Vary by Using Different Definitions? Chronic Disease Epidemiology, BMC Public Health (2015)
15. The Assessment of Family Physicians' Performance in Screening of Hypertension and Diabetes Mellitus in Rural Areas of Isfahan County: A 5-Year Survey, Journal of Isfahan Medical School (2012)
16. Prevalence and Risk Factors of Diabetes Mellitus in the Isfahan City Population (Aged 40 or Over) in 1993, Diabetes Research and Clinical Practice (1997)
17. The Changes in Cardiovascular Disease Risk Factors After the Implementation of the Package of Essential Non-Communicable Disease Control, Journal of Cardiovascular and Thoracic Research (2024)
18. Diabetes and Impaired Glucose Regulation in First-Degree Relatives of Patients With Type 2 Diabetes in Isfahan, Iran: Prevalence and Risk Factors, Review of Diabetic Studies (2007)
19. Clustering of Coronary Artery Disease Risk Factors in Patients With Type 2 Diabetes and Impaired Glucose Tolerance, Eastern Mediterranean Health Journal (2008)
20. Cardiovascular Risk Factors in Relatives of Type 2 Diabetics With Normal Glucose Tolerance Test and Elevated One-Hour Plasma Glucose, Endokrynologia Polska (2010)
21. Metabolic Syndrome in Type 2 Diabetes Mellitus in Isfahan, Iran: Prevalence and Risk Factors, Metabolic Syndrome and Related Disorders (2007)
22. The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study, International Journal of Preventive Medicine (2016)
23. Results of the Program for Prevention and Control of Non-Communicable Diseases in Isfahan, Scientific Journal of Kurdistan University of Medical Sciences (2021)
24. Prevalence of Macro- and Microvascular Complications Among Patients With Type 2 Diabetes in Iran: A Systematic Review, Diabetes Research and Clinical Practice (2009)
25. Incidence of Metabolic Syndrome and Its Risk Factors Among Type 2 Diabetes Clinic Attenders in Isfahan, Iran, Endokrynologia Polska (2012)
26. Determinants of Incident Prediabetes and Type 2 Diabetes in a 7-Year Cohort in a Developing Country: The Isfahan Cohort Study, Journal of Diabetes (2015)
27. Awareness, Treatment and Control of Hypertension, Dyslipidaemia and Diabetes Mellitus in an Iranian Population: The Ihhp Study, Eastern Mediterranean Health Journal (2009)
28. The Product of Triglycerides and Glucose in Comparison With Fasting Plasma Glucose Did Not Improve Diabetes Prediction, Acta Diabetologica (2015)
29. The Prevalence of Impaired Fasting Glucose and Type 2 Diabetes in a Population-Based Sample of Overweight/Obese Children in the Middle East, Pediatric Diabetes (2010)
30. People With Impaired Glucose Tolerance and Impaired Fasting Glucose Are Similarly Susceptible to Cardiovascular Disease: A Study in First-Degree Relatives of Type 2 Diabetic Patients, Annals of Nutrition and Metabolism (2010)
31. Mean Serum Lipid Levels in Iranian Adult Populations: A Systematic Review and Meta-Analysis, Clinical Lipidology (2015)
32. Utility of Serum Lipid Ratios for Predicting Incident Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Diabetes/Metabolism Research and Reviews (2016)
33. Effect of Pharmacist-Led Patient Education on Glycemic Control of Type 2 Diabetics: A Randomized Controlled Trial, Journal of Research in Medical Sciences (2011)
34. The Isfahan Cohort Study: Rationale, Methods and Main Findings, Journal of Human Hypertension (2011)
35. Effects of Gender and Height on the Oral Glucose Tolerance Test: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2008)
36. Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein Versus Metabolic Syndrome Criteria, Journal of Research in Health Sciences (2019)
37. Effect of Pharmacist-Led Patient Education on Glycemic Control of Type 2 Diabetics: A Randomized Controlled Trial, Journal of Research in Medical Sciences (2010)
38. Consumption of Sugar-Sweetened Beverages in Relation to the Metabolic Syndrome Among Iranian Adults, Obesity Facts (2012)
39. Dietary Energy Density and the Metabolic Syndrome Among Iranian Women, European Journal of Clinical Nutrition (2011)
40. The Metabolic Syndrome in Hypertensive and Normotensive Subjects: The Isfahan Healthy Heart Programme, Annals of the Academy of Medicine Singapore (2005)
41. Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis, Iranian Red Crescent Medical Journal (2015)
42. Impact of Health Literacy, Self-Efficacy, and Outcome Expectations on Adherence to Self-Care Behaviors in Iranians With Type 2 Diabetes, Oman Medical Journal (2016)
43. Epidemiologic Evaluation of Stroke Risk Factors Among Rural-Urban Patients in Isfahan University Hospitals, Iran, Journal of Isfahan Medical School (2012)
44. First Report on the Validity of a Continuous Metabolic Syndrome Score As an Indicator for Metabolic Syndrome in a National Sample of Paediatric Population - the Caspian-Iii Study, Endokrynologia Polska (2013)
45. Healthy and Unhealthy Dietary Patterns Are Related to Pre-Diabetes: A Case-Control Study, British Journal of Nutrition (2016)
46. Low-Carbohydrate-Diet Score and Metabolic Syndrome: An Epidemiologic Study Among Iranian Women, Nutrition (2015)
47. The Effects of Macronutrient Intake on the Risk of Pre-Diabetes in First- Degree Relatives of Patients With Type 2 Diabetes, Journal of Isfahan Medical School (2014)
48. Prevalence of Diabetic Retinopathy in Newly Diagnosed Type 2 Diabetic Patients in Isfahan, Iran, Acta Endocrinologica (2008)
49. Prevalence of Metabolic Syndrome According to Atpiii and Idf Criteria in the Iranian Population, Koomesh (2012)
50. Progression to Impaired Glucose Metabolism in First-Degree Relatives of Patients With Type 2 Diabetes in Isfahan, Iran, Diabetes/Metabolism Research and Reviews (2009)